Department of Gynecologic Oncology, La Paz University Hospital, Madrid, Spain.
Department of Gynecology, La Paz University Hospital Hospital Universitario La Paz, Madrid, Spain, 28046, Paseo de la Castellana, 261.
BMC Womens Health. 2023 Sep 14;23(1):488. doi: 10.1186/s12905-023-02633-4.
BACKGROUND: The SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) pandemic changed the distribution of healthcare resources, leading in many cases to the suspension of all non-essential treatments and procedures and representing a challenge for medical professionals. The objective of this study was to evaluate whether clinical protocols in gynecologic oncology care were modified as a result of the pandemic and to assess surgeons' perceptions regarding the management of gynecologic cancers". METHODS: Data were collected through an anonymous and voluntary survey sent via email to healthcare professionals in the field of gynecologic oncology in Spain. RESULTS: A total of 75 gynecologic oncologists completed the online survey. Of these, 93.2% (69) reported working in public hospitals and 62.5% (45) in tertiary care hospitals. 97.3% (71) were affiliated with hospitals treating patients infected with SARS-CoV-2. 85.1% (63) of the respondents expressed concern about the SARS-CoV-2 pandemic and 52.1% (38) indicated that the pandemic impacted the diagnostic and therapeutic quality of care for oncology patients. SARS-CoV-2 nasopharyngeal swab PCR (Polymerase Chain Reaction) testing was always performed before surgical interventions by 97.3% (71), being considered a best practice in triage by 94.4% (68). 87.5% (63) reported no change in the type of surgical approach during the pandemic. 62.5% (45) experienced limitations in accessing special personal protective equipment for SARS-CoV-2. An impact on the follow-up of patients with gynecologic cancers due to the pandemic was reported by 70.4% (50). CONCLUSIONS: Most of the Spanish gynecologic oncologists who responded to our survey reported that the SARS-CoV-2 pandemic had affected their clinical practice. The primary measures implemented were an increase in telemedicine, restricting outpatient visits to high-risk or symptomatic patients and the use of SARS-CoV-2 screening prior to surgery. No major changes in the surgical approach or management of the treatment of ovarian, endometrial or cervical cancer during the pandemic were reported.
背景：SARS-CoV-2（严重急性呼吸系统综合征冠状病毒 2）大流行改变了医疗资源的分布，导致许多情况下所有非必要的治疗和程序都被暂停，这对医疗专业人员来说是一个挑战。本研究的目的是评估妇科肿瘤学护理中的临床方案是否因大流行而发生改变，并评估外科医生对妇科癌症管理的看法。
方法：通过向西班牙妇科肿瘤学领域的医疗保健专业人员发送匿名自愿调查，收集数据。
结果：共有 75 名妇科肿瘤学家完成了在线调查。其中，93.2%（69 名）报告在公立医院工作，62.5%（45 名）在三级保健医院工作。97.3%（71 名）在治疗 SARS-CoV-2 感染患者的医院工作。85.1%（63 名）的受访者对 SARS-CoV-2 大流行表示担忧，52.1%（38 名）表示大流行影响了肿瘤患者的诊断和治疗质量。97.3%（71 名）的受访者在进行外科干预前始终进行 SARS-CoV-2 鼻咽拭子 PCR（聚合酶链反应）检测，94.4%（68 名）认为这是分诊的最佳实践。87.5%（63 名）报告在大流行期间手术方式没有改变。62.5%（45 名）在获得 SARS-CoV-2 专用个人防护设备方面受到限制。70.4%（50 名）报告由于大流行对妇科癌症患者的随访受到影响。
结论：对我们调查做出回应的大多数西班牙妇科肿瘤学家报告说，SARS-CoV-2 大流行影响了他们的临床实践。实施的主要措施包括增加远程医疗、限制高风险或有症状患者的门诊就诊以及在手术前进行 SARS-CoV-2 筛查。在大流行期间，卵巢癌、子宫内膜癌或宫颈癌的手术方法或治疗管理没有发生重大变化。
Int J Gynecol Cancer. 2020-8
Cancer Rep (Hoboken). 2020-10
Int J Gynecol Cancer. 2021-6
Support Care Cancer. 2022-11
JCO Oncol Pract. 2022-7
Int J Gynecol Cancer. 2020-8
Int J Gynecol Cancer. 2020-8
Zotero 插件